[Inhibition of cardiolipin binding antibodies from synovial fluids of patients with arthritis by endotoxin].
In the presented study was prooven that aCl antibodies cross-reacting with LPS (endotoxin) from arthritic synovial fluids are part of the aPL antibodies pool and correlated with presence in joints bacterial cell wall components like LPS-showing endotoxin presence in synovial fluids and they may be usefull in differential diagnosis of the different kind of arthritis and also in explanation of their aetiology at all--especially in cases of early, undifferentiated arthritis.
Zabek
Jakub
J
Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher w Warszawie, Zakład Mikrobiologii i Serologii.
Noworyta
Jacek
J
Brasse-Rumin
Maria
M
Rell-Bakalarska
Maria
M
D017153:Antibodies, Anticardiolipin / Q000276:immunology*; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000032:analysis; D001168:Arthritis / Q000175:diagnosis* / Q000276:immunology*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D015415:Biomarkers / Q000378:metabolism; D003429:Cross Reactions; D003937:Diagnosis, Differential; D006801:Humans; D007159:Immunologic Tests; D008070:Lipopolysaccharides / Q000276:immunology / Q000378:metabolism*; D010003:Osteoarthritis / Q000175:diagnosis / Q000276:immunology; D013582:Synovial Fluid / Q000276:immunology*
D017153:Antibodies, Anticardiolipin; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D015415:Biomarkers; D008070:Lipopolysaccharides